Cargando…
Mediastinal lymphadenopathy and prognosis of COVID-19 disease
BACKGROUND AND OBJECTIVES: There are conflicting studies on the prevalence of mediastinal lymphadenopathy (LAP) and its relationship to the prognosis of COVID-19 disease. The prevalence varied from 3.4 to 66 percent and more prevalent in patients who died. This study aimed to investigate the mediast...
Autores principales: | Pilechian, Sanaz, Pirsalehi, Ali, Arabkoohi, Abolfazl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421590/ https://www.ncbi.nlm.nih.gov/pubmed/34557278 http://dx.doi.org/10.18502/ijm.v13i4.6974 |
Ejemplares similares
-
Association of mediastinal lymphadenopathy with COVID-19 prognosis
por: Sardanelli, Francesco, et al.
Publicado: (2020) -
Mediastinal lymphadenopathy in patients with severe COVID-19
por: Valette, Xavier, et al.
Publicado: (2020) -
Mediastinal lymphadenopathy in COVID-19: A review of literature
por: Taweesedt, Pahnwat Tonya, et al.
Publicado: (2021) -
Mediastinal lymphadenopathy: A serious complication in COVID-19 patients
por: Khatri, Govinda, et al.
Publicado: (2022) -
Mediastinal Lymphadenopathy in a Child with Kawasaki Disease
por: Javadi, Vadood, et al.
Publicado: (2020)